NCT06707506Completed
Atrial Fibrillation Risk After Miniinvasive Mitral Valve Repair
CT-Derived Metabolic Parameters as Predictors of Post-Operative Atrial Fibrillation Following Minimally Invasive Mitral Valve Surgery: The MiniMitral AF Study
Source: ClinicalTrials.gov · Last updated 27 Nov 2024
Brief summary (registry, in English)
This retrospective cohort study investigates how CT-derived tissue quality parameters, serving as markers of metabolic status, predict post-operative atrial fibrillation risk in patients undergoing minimally invasive mitral valve surgery. The study leverages established associations between adipose tissue characteristics and metabolic dysfunction to explore their potential role in post-surgical arrhythmogenesis.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 114 (actual)
- First submitted
- 24 Nov 2024
- Start date
- 1 Jan 2014
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- Nemocnice AGEL Trinec-Podlesi a.s.
- Diseases
- Atrial fibrillation
- NCT number
- NCT06707506
What you commit to
- Study type: Observational
- Participants enrolled: 114
- From 1 Jan 2014 to the primary completion date, 30 Nov 2023
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous cardiac surgery
Other
- Incomplete clinical data
- Poor quality CT images
Who the study is looking for
- Age ≥ 18 years
- Undergoing minimally invasive mitral valve surgery
- Preoperative CT scan available
- Surgery between January 2014 and November 2023
Age in the registry: 19 years to 110 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.